In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae

被引：25

作者：

Welsh, L

Gaydos, C

Quinn, TC

机构：

[1] JOHNS HOPKINS UNIV,SCH MED,DIV INFECT DIS,BALTIMORE,MD 21205

[2] NIAID,IMMUNOREGULAT LAB,BETHESDA,MD 20892

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1996年 / 40卷 / 01期

关键词：

D O I：

10.1128/AAC.40.1.212

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Thirteen strains of Chlamydia pneumoniae were evaluated for their in vitro susceptibilities to azithromycin, clarithromycin, erythromycin, and tetracycline. The MIC ranges were 0.125 to 0.5 mu g/ml for azithromycin, 0.031 to 1.0 mu g/ml for clarithromycin, 0.125 to 1.0 mu g/ml for erythromycin, and 0.125 to 1.0 mu g/ml for tetracycline, The ranges for the minimal lethal concentrations were 0.125 to 0.5 mu g/ml for azithromycin. 0.031 to 1.0 mu g/ml for clarithromycin, 0.125 to 1.0 mu g/ml for erythromycin, and 0.25 to 1.0 mu g/ml for tetracycline. Clarithromycin and azithromycin were the most active antibiotics against C. pneumoniae in vitro.

引用

页码：212 / 214

页数：3

共 50 条

[41] In-vitro activity of dirithromycin against Chlamydia pneumoniae
Roblin, PM
Kutlin, A
Sokolovskaya, N
Hammerschlag, MR
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (05) : 647 - 649
[42] In vitro activities of azithromycin, telitbromycin and levofloxacin against Chlamydophila pneumoniae in an acute and in a continuous-infection model
Caronzolo, D
Lucini, V
Grosso, S
Pannacci, M
Colleoni, F
Scaglione, F
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S209 - S209
[43] In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
Banche, G.
Roana, J.
Allizond, V.
Andreotti, S.
Malabaila, A.
Vigni, N. Li
Mandras, N.
Scalas, D.
Tullio, V.
Carlone, N. A.
Savoia, D.
Gaido, E.
Barbui, A.
Cuffini, A. M.
[J]. LETTERS IN APPLIED MICROBIOLOGY, 2008, 47 (04) : 309 - 314
[44] Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes
Goldstein, EJC
Citron, DM
Merriam, CV
Warren, Y
Tyrrell, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2801 - 2805
[45] In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae
Neuhauser, MM
Prause, JL
Danziger, LH
Pendland, SL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 1132 - 1134
[46] In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis
Roblin, PM
Hammerschlag, MR
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (01) : 61 - 63
[47] Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae
Bergman, KL
Olsen, KM
Peddicord, TE
Fey, PD
Rupp, ME
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1291 - 1293
[48] Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae
Ameyama, S
Shinmura, Y
Takahata, M
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2327 - 2329
[49] INVITRO ACTIVITIES OF 5 QUINOLONES AGAINST CHLAMYDIA-PNEUMONIAE
HAMMERSCHLAG, MR
HYMAN, CL
ROBLIN, PM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) : 682 - 683
[50] Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae
Ren, Huan
Zhang, Jingyi
Zhou, Jingyi
Xu, Congjuan
Fan, Zheng
Pan, Xiaolei
Li, Shouyi
Liang, Yuying
Chen, Shuiping
Xu, Jun
Wang, Penghua
Zhang, Yanhong
Zhu, Guangbo
Liu, Huimin
Jin, Yongxin
Bai, Fang
Cheng, Zhihui
Pletzer, Daniel
Wu, Weihui
[J]. JOURNAL OF ANTIBIOTICS, 2021, 74 (08): : 528 - 537

← 1 2 3 4 5 →